E-ISSN 2149-2530
Original Article
Influence of Statin Therapy on Exacerbation Frequency in Patients with Chronic Obstructive Pulmonary Disease
1 Department of Pulmonolgy and Intensive Care, Marmara University School of Medicine, İstanbul, Turkey  
2 Department of Pulmonolgy, Başkent University School of Medicine, Ankara, Turkey  
turkthoracj 2017; 18: 29-32
DOI: 10.5152/TurkThoracJ.2017.16051
This article was viewed 578 times, downloaded 435 times

Key Words: Statin, COPD, exacerbations
Abstract

OBJECTIVES: Chronic obstructive pulmonary disease (COPD) is an inflammatory disease, in which chronic and systemic inflammation plays an important role. By decreasing neutrophil infiltration and cytokine production, statins have anti-inflammatory mechanisms.

 

MATERIALS AND METHODS: Fifty-seven patients who had diagnosis of chronic obstructive pulmonary disease according to GOLD guideline were included in the study; 20 of them were statin users. Statin users group were patients being under medication with regular simvastatin, atorvastatin or rosuvastatin 20 mg per day for at least the past 1 year.

 

RESULTS: There was statistically no significant difference between patients with or without statin treatment with respect to; age, female-male ratio, COPD severity level, medication used for COPD, pulmonary function tests results and smoking habits. COPD exacerbation frequency in patients using statins was significantly less than patients not using statins (p<0.05). Patient number with COPD exacerbation, antibiotic treatment and outpatient clinic administration and outpatient clinic administration frequency was significantly lower in statin using patients (p<0.05).

 

CONCLUSION: COPD patients receiving statins have a lower frequency of COPD exacarbations, hospital administration and antibiotic treatment compared to patients not receiving statins.

Key Words
Authors
All
Author's Corner
Survey
AVES | Copyright © 2017 Turkish Thoracic Society Latest Update: 17.10.2017